Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 17.65 ▲ 0.02 (0.11%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Amarin | AMRN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.35 | 2.03% | 17.63 | 17.91 | 17.25 | 17.27 | 17.28 | 19:58:12 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 17.65 | 17.74 | 0.09 | 0.51% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 25,618 | 6,097,758 | $ 17.58 | $ 107,190,896 | 7,129,615 | 2.35 - 23.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:11 | formt | 150 | $ 17.65 | USD |
Amarin Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 5.83B | 330.69M | $ -116.45M | -0.39 | 0.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | -289.06k | 54.60% |
Amarin News
Current Report Filing (8-k) Edgar (US Regulatory) • Thu May 23, 2019 5:02 PM (2 days ago)
Vascepa® to Be Featured in Multiple Scientific Sessions at the National Lipid Association Annual Meeting GlobeNewswire Inc. • 
• Thu May 16, 2019 4:15 PM (1 week ago)
• Thu May 16, 2019 4:15 PM (1 week ago)Quarterly Report (10-q) Edgar (US Regulatory) • Wed May 01, 2019 6:50 AM (3 weeks ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Wed May 01, 2019 6:49 AM (3 weeks ago)
Amarin Reports First Quarter 2019 Financial Results and Provides Update on Operations GlobeNewswire Inc. • • Wed May 01, 2019 5:00 AM (3 weeks ago)
• Wed May 01, 2019 5:00 AM (3 weeks ago)New Drug Submission Filed for Vascepa® with Health Canada GlobeNewswire Inc. • • Mon Apr 29, 2019 6:00 AM (4 weeks ago)
• Mon Apr 29, 2019 6:00 AM (4 weeks ago)Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) • Thu Apr 25, 2019 7:02 AM (1 month ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMRN Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 17.28 | 18.015 | 16.78 | 17.3586 | 3M | 6M | 4M | 0.35 | 2.03% |
| 1 Month | 19.05 | 19.75 | 16.2 | 17.6772 | 3M | 10M | 5M | -1.42 | -7.45% |
| 3 Months | 20.67 | 23.25 | 16.2 | 19.2154 | 3M | 40M | 7M | -3.04 | -14.71% |
| 6 Months | 19.63 | 23.25 | 11.75 | 17.9120 | 2M | 40M | 7M | -2 | -10.19% |
| 1 Year | 2.99 | 23.335 | 2.35 | 15.7106 | 1M | 160M | 9M | 14.64 | 489.63% |
| 3 Years | 1.82 | 23.335 | 1.77 | 11.6834 | 304k | 160M | 4M | 15.81 | 868.68% |
| 5 Years | 1.33 | 23.335 | 0.78 | 9.3363 | 38k | 160M | 3M | 16.3 | 1,225.56% |
Amarin Description
| Amarin Corporation PLC is a biopharmaceutical company that commercializes and develops therapeutics to improve cardiovascular health. |
